Literature DB >> 20633031

Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes.

D MacGlashan1.   

Abstract

BACKGROUND: Activation of human basophils results in the release of many different mediators and the expression of new cell surface proteins. The markers CD63 and CD203c have been used in recent years to assess basophil activation but there have been many studies that demonstrate that expression of these markers can be dissociated from histamine release.
OBJECTIVE: To determine the signal transduction requirements for CD203c and CD63 expression.
METHODS: The current study began by exploring the dependency of CD203c and CD63 expression on protein kinase C (PKC) using known selective inhibitors of PKC.
RESULTS: Between 30 and 300 nm, Ro-31-8220 and bisindoylmaleimide II (Bis II) had no effect on formyl-met-leu-phe- or anti-IgE-induced CD63 or CD203c but enhanced IgE-mediated expression of CD63 by an average of 15-fold at concentrations >1 microm. These results led to the suggestion that these inhibitors altered the normal pathways of degranulation (by a non-PKC dependent mechanism), shifting the normal presence of piecemeal degranulation to the process termed anaphylactic degranulation (AND). Morphological studies demonstrated that concentrations of Ro-31-8220 and Bis II>1 mum dramatically increased the presence of degranulation sacs, a morphological feature of AND.
CONCLUSION: It is proposed that CD63 expression results from only the AND form of histamine release.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20633031      PMCID: PMC2927965          DOI: 10.1111/j.1365-2222.2010.03572.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  48 in total

1.  Dynamics of intracellular granules with CD63-GFP in rat basophilic leukemia cells.

Authors:  T Amano; T Furuno; N Hirashima; N Ohyama; M Nakanishi
Journal:  J Biochem       Date:  2001-05       Impact factor: 3.387

2.  Graded changes in the response of individual human basophils to stimulation: distributional behavior of events temporally coincident with degranulation.

Authors:  D W MacGlashan
Journal:  J Leukoc Biol       Date:  1995-08       Impact factor: 4.962

3.  Syk expression in peripheral blood leukocytes, CD34+ progenitors, and CD34-derived basophils.

Authors:  Susan S Ishmael; Donald W MacGlashan
Journal:  J Leukoc Biol       Date:  2009-11-04       Impact factor: 4.962

4.  Graded changes in the response of individual human basophils to stimulation: distributional behavior of early activation events.

Authors:  D W MacGlashan; B S Bochner; J A Warner
Journal:  J Leukoc Biol       Date:  1994-01       Impact factor: 4.962

5.  Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients.

Authors:  K Sonneck; C Baumgartner; L Rebuzzi; K Marth; K W Chen; A W Hauswirth; S Florian; S Vrtala; H J Bühring; R Valenta; P Valent
Journal:  Int J Immunopathol Pharmacol       Date:  2008 Jan-Mar       Impact factor: 3.219

6.  Dissociation of IgE from receptors on human basophils. I. Enhanced passive sensitization for histamine release.

Authors:  J J Pruzansky; L C Grammer; R Patterson; M Roberts
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

7.  Biphasic Ca2+ responses in human basophils. Evidence that the initial transient elevation associated with the mobilization of intracellular calcium is an insufficient signal for degranulation.

Authors:  D MacGlashan; L M Botana
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

Review 8.  Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls.

Authors:  A L de Weck; M L Sanz; P M Gamboa; W Aberer; J Bienvenu; M Blanca; P Demoly; D G Ebo; L Mayorga; G Monneret; J Sainte-Laudy
Journal:  Int Arch Allergy Immunol       Date:  2008-02-11       Impact factor: 2.749

9.  Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo.

Authors:  Stefan Kraft; Tony Fleming; James M Billingsley; Shih-Yao Lin; Marie-Hélène Jouvin; Peter Storz; Jean-Pierre Kinet
Journal:  J Exp Med       Date:  2005-01-31       Impact factor: 14.307

10.  Differential response of human basophil activation markers: a multi-parameter flow cytometry approach.

Authors:  Salvatore Chirumbolo; Antonio Vella; Riccardo Ortolani; Marzia De Gironcoli; Pietro Solero; Giuseppe Tridente; Paolo Bellavite
Journal:  Clin Mol Allergy       Date:  2008-10-16
View more
  59 in total

Review 1.  Assessing basophil functional measures during monoclonal anti-IgE therapy.

Authors:  Sarbjit S Saini; Donald W MacGlashan
Journal:  J Immunol Methods       Date:  2012-06-01       Impact factor: 2.303

2.  Monitoring of CD63% in basophil activation test and suggested new parameters for allergy diagnosis.

Authors:  Salvatore Chirumbolo
Journal:  Inflamm Res       Date:  2011-12-29       Impact factor: 4.575

3.  Marked differences in the signaling requirements for expression of CD203c and CD11b versus CD63 expression and histamine release in human basophils.

Authors:  Donald MacGlashan
Journal:  Int Arch Allergy Immunol       Date:  2012-06-20       Impact factor: 2.749

4.  Delayed clinical and ex vivo response to mammalian meat in patients with IgE to galactose-alpha-1,3-galactose.

Authors:  Scott P Commins; Hayley R James; Whitney Stevens; Shawna L Pochan; Michael H Land; Carol King; Susan Mozzicato; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2014-03-20       Impact factor: 10.793

5.  Data-driven programmatic approach to analysis of basophil activation tests.

Authors:  Sarita U Patil; Agustin Calatroni; Michael Schneider; Johanna Steinbrecher; Neal Smith; Cecilia Washburn; Alex Ma; Wayne G Shreffler
Journal:  Cytometry B Clin Cytom       Date:  2017-07-05       Impact factor: 3.058

6.  Basophil reactivity, wheal size, and immunoglobulin levels distinguish degrees of cow's milk tolerance.

Authors:  Lara S Ford; Katherine A Bloom; Anna H Nowak-Węgrzyn; Wayne G Shreffler; Madhan Masilamani; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2012-07-20       Impact factor: 10.793

7.  Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children.

Authors:  A Thyagarajan; S M Jones; A Calatroni; L Pons; M Kulis; C S Woo; M Kamalakannan; B P Vickery; A M Scurlock; A Wesley Burks; W G Shreffler
Journal:  Clin Exp Allergy       Date:  2012-08       Impact factor: 5.018

Review 8.  Pros and Cons of Clinical Basophil Testing (BAT).

Authors:  Hans Jürgen Hoffmann; Edward F Knol; Martha Ferrer; Lina Mayorga; Vito Sabato; Alexandra F Santos; Bernadette Eberlein; Anna Nopp; Donald MacGlashan
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

Review 9.  Applications and mechanisms of immunotherapy in allergic rhinitis and asthma.

Authors:  Jasper H Kappen; Stephen R Durham; Hans In 't Veen; Mohamed H Shamji
Journal:  Ther Adv Respir Dis       Date:  2016-09-27       Impact factor: 4.031

10.  Spatiotemporally and mechanically controlled triggering of mast cells using atomic force microscopy.

Authors:  Kenneth K Hu; Marc A Bruce; Manish J Butte
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.